Finance

Lists
002399:SHE
Shenzhen Hepalink Pharma Group Co Ltd
CN¥9.08
-0.44%
(-0.040) 1D
Nov 17, 3:04:12 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002399...
Open
CN¥9.02
High
CN¥9.18
Low
CN¥9.02
Mkt. cap
12.13B
Avg. vol.
3.07M
Volume
1.78M
Dividend
1.60%
Quarterly dividend
CN¥0.04
Ex-dividend date
Jun 18, 2026
P/E ratio
70.19
52-wk high
CN¥12.64
52-wk low
CN¥8.50
EPS
CN¥0.13
Shares outstanding
1.25B
No. of employees
2K
Open
CN¥9.02
High
CN¥9.18
Low
CN¥9.02
Mkt. cap
12.13B
Avg. vol.
3.07M
Volume
1.78M
Dividend
1.60%
Quarterly dividend
CN¥0.04
Ex-dividend date
Jun 18, 2026
P/E ratio
70.19
52-wk high
CN¥12.64
52-wk low
CN¥8.50
EPS
CN¥0.13
Shares outstanding
1.25B
No. of employees
2K
News stories
From web sources and news partners
About Shenzhen Hepalink Pharma Group Co Ltd
CEO-
Employees2.1K
FoundedApr 21, 1998
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.28B
1.33B
1.25B
1.22B
Cost of goods sold
900.40M
876.31M
826.48M
789.21M
Cost of revenue
900.40M
876.31M
826.48M
789.21M
Research and development expenses
50.33M
36.44M
45.89M
50.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
252.73M
209.31M
238.09M
223.41M
Operating expense
336.08M
263.62M
301.09M
285.24M
Total operating expenses
1.24B
1.14B
1.13B
1.07B
Operating income
48.03M
190.92M
121.10M
142.87M
Other non operating income
-254.18M
-122.99M
121.83M
-197.71M
EBT including unusual items
-239.36M
207.68M
72.85M
127.95M
EBT excluding unusual items
-97.72M
93.38M
76.27M
105.61M
Income tax expense
-29.37M
20.31M
-14.68M
9.52M
Effective tax rate
12.27%
9.78%
-20.15%
7.44%
Other operating expenses
16.33M
8.11M
7.92M
6.94M
Net income
-204.09M
187.57M
87.71M
118.61M
Net profit margin
-15.89%
14.09%
7.02%
9.74%
Earnings per share
-
-
-
-
Interest and investment income
-
38.50M
1.33M
16.17M
Interest expense
-32.17M
-13.05M
-12.63M
-11.08M
Net interest expenses
-32.17M
25.45M
-11.30M
5.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
128.19M
271.08M
201.09M
223.03M
Gain or loss from assets sale
-1.84M
-
26.67K
-26.67K
Upcoming events
AI content may include mistakes. Learn more
Google apps